Darren S. Cline's Insider Trades & SAST Disclosures
Darren S. Cline's most recent trade in Pliant Therapeutics Inc was a trade of 26,764 Common Stock (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Darren S. Cline.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Pliant Therapeutics Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 26,764 | 26,764 | - | - | Common Stock (Right to Buy) | |
|
Pyxis Oncology Inc
|
Cline Darren S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2024 | 35,219 | 251,405 | - | 0 | Common Stock | |
|
Impel Pharmaceuticals Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 13,222 | 13,222 | - | - | Stock Option (right to buy) | |
|
Pliant Therapeutics Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
|
Impel Pharmaceuticals Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 20,013 | 20,013 | - | - | Stock Option (right to buy) | |
|
Pyxis Oncology Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2023 | 139,355 | 216,186 | - | 0 | Common Stock | |
|
Pliant Therapeutics Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
|
Pyxis Oncology Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 66,831 | 76,831 | - | 0 | Common Stock | |
|
Pyxis Oncology Inc
|
Darren S. Cline | Director | Purchase of securities on an exchange or from another person at price $ 9.39 per share. | 08 Dec 2021 | 10,000 | 10,000 | - | 9.4 | 93,885 | Common Stock |
|
Pyxis Oncology Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 42,191 | 42,191 | - | - | Stock Option (Right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges